Cargando…

Integrated analysis of potential gene crosstalk between non-alcoholic fatty liver disease and diabetic nephropathy

BACKGROUND: Growing evidence indicates that non-alcoholic fatty liver disease (NAFLD) is related to the occurrence and development of diabetic nephropathy (DN). This bioinformatics study aimed to explore optimal crosstalk genes and related pathways between NAFLD and DN. METHODS: Gene expression prof...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Qianqian, Zhao, Zihao, Liu, Dongwei, Li, Jia, Pan, Shaokang, Duan, Jiayu, Dong, Jiancheng, Liu, Zhangsuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642911/ https://www.ncbi.nlm.nih.gov/pubmed/36387855 http://dx.doi.org/10.3389/fendo.2022.1032814

Ejemplares similares

Integrated analysis of RNA methylation regulators crosstalk and immune infiltration for predictive and personalized therapy of diabetic nephropathy
por: Li, Jia, et al.
Publicado: (2023)

Relationship between serum iPTH and peritonitis episodes in patients undergoing continuous ambulatory peritoneal dialysis
por: Zhao, Zihao, et al.
Publicado: (2023)

Corrigendum: Relationship between serum iPTH and peritonitis episodes in patients undergoing continuous ambulatory peritoneal dialysis
por: Zhao, Zihao, et al.
Publicado: (2023)

Integration of Metabolomics and Proteomics in Exploring the Endothelial Dysfunction Mechanism Induced by Serum Exosomes From Diabetic Retinopathy and Diabetic Nephropathy Patients
por: Yang, Jing, et al.
Publicado: (2022)

Concise review: current trends on applications of stem cells in diabetic nephropathy
por: Liu, Dongwei, et al.
Publicado: (2020)

NLRP3-mediated pyroptosis in diabetic nephropathy
por: Wan, Jiayi, et al.
Publicado: (2022)

Integrative Analysis of m(6)A Regulator-Mediated RNA Methylation Modification Patterns and Immune Characteristics in Lupus Nephritis
por: Zhao, Huanhuan, et al.
Publicado: (2021)

Lysine Acetylation in the Proteome of Renal Tubular Epithelial Cells in Diabetic Nephropathy
por: Wan, Jiayi, et al.
Publicado: (2021)

Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy
por: Yang, Jing, et al.
Publicado: (2022)

Liver-bone crosstalk in non-alcoholic fatty liver disease: Clinical implications and underlying pathophysiology
por: Zhao, Jiahui, et al.
Publicado: (2023)

The role of cellular crosstalk in the progression of diabetic nephropathy
por: Zhang, Keying, et al.
Publicado: (2023)

Prediction and Risk Stratification of Cardiovascular Disease in Diabetic Kidney Disease Patients
por: Ren, Jingjing, et al.
Publicado: (2022)

The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis
por: Guo, Runzhi, et al.
Publicado: (2023)

Diabetic Nephropathy: Perspective on Extracellular Vesicles
por: Lu, Yanfang, et al.
Publicado: (2020)

HNRNPA1-mediated exosomal sorting of miR-483-5p out of renal tubular epithelial cells promotes the progression of diabetic nephropathy-induced renal interstitial fibrosis
por: Liu, DongWei, et al.
Publicado: (2021)

Stem cells: a potential treatment option for kidney diseases
por: Liu, Dongwei, et al.
Publicado: (2020)

Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: a cross-sectional survey
por: Duan, Jiayu, et al.
Publicado: (2019)

Telitacicept for autoimmune nephropathy
por: Cai, Jingjing, et al.
Publicado: (2023)

Contribution of Liver and Pancreatic Islet Crosstalk to β-Cell Function/Dysfunction in the Presence of Fatty Liver
por: López-Bermudo, Lucía, et al.
Publicado: (2022)

Integrated Analysis of Multiple Microarray Studies to Identify Novel Gene Signatures in Non-alcoholic Fatty Liver Disease
por: Jia, Xi, et al.
Publicado: (2019)

Endotoxins and Non-Alcoholic Fatty Liver Disease
por: Kessoku, Takaomi, et al.
Publicado: (2021)

The Interplay of Renin-Angiotensin System and Toll-Like Receptor 4 in the Inflammation of Diabetic Nephropathy
por: Feng, Qi, et al.
Publicado: (2020)

Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)
por: Cuthbertson, Daniel J., et al.
Publicado: (2021)

Integrated analysis for treatment scheme of sodium–glucose cotransporter 2 inhibitors in patients with diabetic kidney disease: a real-world study
por: Fang, Li, et al.
Publicado: (2023)

Gut Dysfunction and Non-alcoholic Fatty Liver Disease
por: Grabherr, Felix, et al.
Publicado: (2019)

Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology
por: Memaj, Plator, et al.
Publicado: (2022)

The change of non-alcoholic fatty liver disease is associated with risk of incident diabetes
por: Chen, Congling, et al.
Publicado: (2023)

The Expression of Tristetraprolin and Its Relationship with Urinary Proteins in Patients with Diabetic Nephropathy
por: Liu, Fengxun, et al.
Publicado: (2015)

Metabolic Understanding of the Genetic Dysregulation in the Tumor Microenvironment of Kidney Renal Clear Cell Carcinoma
por: Xie, Junwei, et al.
Publicado: (2022)

Impact of Porphyromonas gingivalis-odontogenic infection on the pathogenesis of non-alcoholic fatty liver disease
por: Liu, Linbo, et al.
Publicado: (2023)

Oxidation-Specific Epitopes in Non-Alcoholic Fatty Liver Disease
por: Hendrikx, Tim, et al.
Publicado: (2020)

Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease
por: Maruszczak, Katharina, et al.
Publicado: (2022)

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
por: Rong, Li, et al.
Publicado: (2023)

Erratum: Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology
Publicado: (2023)

Analysis of potential biomarkers for diabetic kidney disease based on single-cell RNA-sequencing integrated with a single-cell sequencing assay for transposase-accessible chromatin
por: Shi, Yan, et al.
Publicado: (2023)

Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes
por: Scapaticci, Serena, et al.
Publicado: (2021)

Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes
por: Bayliss, Jacqueline, et al.
Publicado: (2021)

The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease
por: Grefhorst, Aldo, et al.
Publicado: (2021)

Autonomic Imbalance Increases the Risk for Non-alcoholic Fatty Liver Disease
por: Jung, Inha, et al.
Publicado: (2021)

Exercise intervention improves mitochondrial quality in non-alcoholic fatty liver disease zebrafish
por: Zou, Yun-Yi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_clnscf44n8gvpr16pualkee0sd